Sign in

Research summary ·

All-cause mortality and appropriate implantable cardioverter-defibrillator shocks with first-line catheter ablation versus antiarrhythmic drugs in ischemic ventricular tachycardia: A systematic review and Meta-analysis of randomized controlled trials.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study pooled results from earlier trials. Each trial put people into groups by chance. People had heart muscle damage from poor blood flow. They also had a fast heart rhythm called VT. All had an implanted device that can shock the heart. None had taken rhythm drugs before. The trials compared ablation, a procedure on the heart, with rhythm drugs. In all, 618 people took part.

What they found

Deaths from any cause did not differ clearly between the groups. A second way of checking deaths gave a similar picture. People who had ablation had fewer shocks from their device. Bouts of many VT episodes, called VT storm, did not differ clearly. Hospital stays for heart failure also did not differ clearly.

What it means for patients

For these people, ablation as a first step cut device shocks. It did not clearly lower the risk of death. The authors say there is not yet enough data to judge survival.

Why it is not certain yet

The authors say the death analysis was too small to be sure. The trials followed people for different lengths of time. The abstract does not say how long people were followed. A review can only be as good as the studies in it.

Source

All-cause mortality and appropriate implantable cardioverter-defibrillator shocks with first-line catheter ablation versus antiarrhythmic drugs in ischemic ventricular tachycardia: A systematic review and Meta-analysis of randomized controlled trials.

PubMed · PMID 42722298

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Ventricular tachycardia publications